Search results
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 7 hours agoGeron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Has Geron (GERN) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 2 years agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Geron (GERN) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoGeron (GERN) closed at $3.34 in the latest trading session, marking a -1.18% move from the prior...
Biotech Stock Roundup: GERN Surges on Study Data, PHAT, VERA Offer Updates & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, Geron...
Geron (GERN) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 11 months agoGeron Corporation (GERN) reached a significant support level, and could be a good pick for investors...
Geron (GERN) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on the updates related to Geron Corporation’s GERN pipeline when it...
Geron Corporation's (NASDAQ:GERN) Intrinsic Value Is Potentially 95% Above Its Share Price
Simply Wall St. via Yahoo Finance· 2 years agoDoes the September share price for Geron Corporation (NASDAQ:GERN) reflect what it's really worth?...
Geron (GERN) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 5 months agoGeron (GERN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an...
Geron (GERN) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 months agoImage source: The Motley Fool. Geron (NASDAQ: GERN) Q4 2023 Earnings Call Feb 28, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks via Yahoo Finance· 1 month agoIt was a busy week for the biotech sector with lots of study data readouts and regulatory approvals....